Safety of Polysorbate 80 in the Oncology Setting.
Schwartzberg LS, Navari RM.
Schwartzberg LS, et al.
Adv Ther. 2018 Jun;35(6):754-767. doi: 10.1007/s12325-018-0707-z. Epub 2018 May 23.
Adv Ther. 2018.
PMID: 29796927
Free PMC article.
Review.
Recently, two polysorbate 80-free agents have been approved: intravenous rolapitant, which is a neurokinin 1 (NK-1) receptor antagonist formulated with the synthetic surfactant polyoxyl 15 hydroxystearate, and intravenous HTX-019, which is a novel NK-1 recept …
Recently, two polysorbate 80-free agents have been approved: intravenous rolapitant, which is a neurokinin 1 (NK-1) receptor antagonist form …